NasdaqGS:STOKBiotechs
A Look At Stoke Therapeutics (STOK) Valuation After Strong 1 Year Shareholder Returns
Stoke Therapeutics (STOK) has drawn fresh investor attention after recent share price moves, with the stock showing mixed short term performance and gains over the past 3 months and year.
See our latest analysis for Stoke Therapeutics.
At a share price of $33.08, Stoke Therapeutics has seen a 1 day share price return of 1.10%, while its 1 year total shareholder return of 243.51% reflects recent momentum following a slower multi year record.
If you are comparing Stoke with other high growth...